Volume : 09, Issue : 10, October – 2022

Title:

29.THE ACCURACY OF POINT OF CARE HBA1C IN SCREENING FOR TYPE 2 DIABETES IN ASYMPTOMATIC ADULTS: META-ANALYSIS

‬

Authors :

Ali Darraj, Mazen Ferwana

Abstract :

Background: Diabetes Mellitus represent a major health problem of the 21st century, according to International Diabetic Federation (IDF), three of the Arabian Gulf countries have the highest prevalence of type 2 diabetes worldwide including Saudi Arabia. Screening for diabetes mellitus by using HbA1c point of care devices is a new quick and relatively cheap method.
Objective: To collect and combine the available data about the correlation between point of care HbA1c (POC HbA1c) testing and laboratory HbA1c measurement in screening for asymptomatic adult participants for type 2 diabetes.
Method: We searched databases for studies addressing the correlation between point of care HbA1c in the screening of type 2 diabetes and laboratory HbA1c measurement (reference method), for asymptomatic adult participants. Risk of bias was assessed using Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS-2). Screening accuracy measures were pooled using the random-effects model and subgroup, and sensitivity analyses were conducted.
Results: Out of 11919 studies identified, only 4 met the eligibility criteria. Three POC HbA1c devices were reviewed in this analysis: A1cNow+, Afinion, and Que-test devices.
The included studies have a moderate risk of bias, and the pooled results showed a strong positive correlation between POC HbA1c testing and laboratory HbA1c measurement (correlation coefficient, 0.935; 95% confidence interval, 0.893–0.961); however, there is substantial heterogeneity.
Conclusion: The pooled results showed a strong positive correlation between point of care HbA1c devices and standard laboratory HbA1c method in screening for type 2 diabetes.
Key words: Screening, Type 2 Diabetes Mellitus, Glycemic control, HbA1c, Point of Care (POC), A1cNow+, Afinion, and Que-test, Meta-analysis

Cite This Article:

REFERENCES:

1. Organization WH. Diabetes Fact sheet Number 312 Geneva [updated January 2015; cited 2015 15/07/15]. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/.
2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes research and clinical practice. 2014;103(2):137-49.
3. Fatani HH, Mira SA, el-Zubier AG. Prevalence of diabetes mellitus in rural Saudi Arabia. A reply. Diabetes care. 1988;11(3):297.
4. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Sabico SL, et al. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC medicine. 2011;9:76.
5. Al-Rubeaan K, Al-Manaa HA, Khoja TA, Ahmad NA, Al-Sharqawi AH, Siddiqui K, et al. Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI-DM study. Journal of diabetes. 2014.
6. Menke, Andy, et al. “Prevalence of and trends in diabetes among adults in the United States, 1988-2012.” Jama 314.10 (2015): 1021-1029 Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract. 2014;103(2):150-60.
7. http://care.diabetesjournals.org/content/suppl/2015/12/21/39.Supplement_1.DC2/2016-Standards-of-Care.pdf
8. Organization WH. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus (abbreviated Report of a WHO Consultation). 2011.
9. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada [Internet]. Ottawa, ON: Canadian Diabetes Association; 2013 [cited 2013 Sep 19]. 212 p. Available from: http://guidelines.diabetes.ca/App_Themes/CDACPG/resources/cpg_2013_full_en.pdf
10. English E, Milosovich ET, John WG. In vitro determination of hemoglobin A1c for diabetes diagnosis and management: technology update. Pathology and Laboratory Medicine International.
11. 2014;6:21-31.
12. Al-Ansary L, Farmer A, Hirst J, Roberts N, Glasziou P, Perera R, et al. Point-of-Care Testing for Hb A(1c) in the Management of Diabetes: A Systematic Review and Meta-analysis. Clinical Chemistry. 2011;57(4):568-76.
13. Larissa-Nele Schaffert, Emma English, Carl Heneghan, Christopher P. Price, Ann Van den Bruel, Annette Plüddemann. Point-of-care HbA1c tests – diagnosis of diabetes. Horizon scan report 0044 March 2016.
14. English E, Milosovich ET, John WG. In vitro determination of hemoglobin A1c for diabetes diagnosis and management: technology update. Pathology and Laboratory Medicine International. 2014;6:21-31.
15. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011 Jun;57(6):e1-e47.
16. National Glycohemoglobin Standardization Program. Obtaining certification [Internet]. Missouri: National Glycohemoglobin Standardization Program; 2013 [cited 2013 Sep 19]. 7 p. Available from: http://www.ngsp.org/cert/Manufinfo1113.pdf.
17. Health Quality Ontario. Point-of-care hemoglobin A1c testing: an evidence-based analysis. Ont Health Technol Assess Ser [Internet]. 2014 July;14(8):1–30. Available from: http://www.hqontario.ca/evidence/publications-and-ohtac-recommendations/ontario-health-technology-assessment-series/eba-point-of-care-a1c
18. Chadee A, Blackhouse G, Goeree R. Point-of-Care Hemoglobin A1c Testing: A Budget Impact Analysis. Health Technology Assessment (HTA) Database. 2014.
19. Wiwanitkit V. Comparison of costs of hemoglobin a1c determination by point-of-care testing (POCT) and standard hemoglobin a1c analyzer. Archives of Hellenic Medicine. 2010;27:953-5.
20. Organization WH. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus (abbreviated Report of a WHO Consultation). 2011.
21. Bode BW, Irvin BR, Pierce JA, et al. Advances in hemoglobin A1c point of care technology. J Diabetes Sci Technol. 2007;1(3):405–11.
22. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-536 [PMID: 22007046 DOI: 10.7326/0003-4819-155-8-201110180-00009].
23. MedCalc Statistical Software version 16.4.3 (MedCalc Software bvba, Ostend, Belgium; https://www.medcalc.org; 2016.
24. Larissa-Nele Schaffert, Emma English, Carl Heneghan, Christopher P. Price, Ann Van den Bruel, Annette Plüddemann. Point-of-care HbA1c tests – diagnosis of diabetes. Horizon scan report 0044 March 2016.
25. MedCalc Statistical Software version 16.4.3 (MedCalc Software bvba, Ostend, Belgium; https://www.medcalc.org; 2016.
26. Larissa-Nele Schaffert, Emma English, Carl Heneghan, Christopher P. Price, Ann Van den Bruel, Annette Plüddemann. Point-of-care HbA1c tests – diagnosis of diabetes. Horizon scan report 0044 March 2016.